Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Acta Trop ; 199: 105154, 2019 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-31445897

RESUMO

Tuberculosis remains a major global health threat killing millions of people. Due to existing multiple drug resistance (MDR) and prolonged treatment it becomes necessary to explore novel drug targets in Mycobacterium tuberculosis (Mtb). DnaG primase, having a significant role in primer synthesis during initiation of DNA replication, has emerged as a promising drug target. The three dimensional (3D) model of its catalytic domain (Toprim) was constructed. Further, in silico screening of the three diverse chemical compound libraries against the modeled domain was carried out. Four top screened compounds were identified and evaluated by ADMET analysis. The stability of these compounds in complex with the Toprim domain was validated through 50 ns molecular dynamics simulations. Lys 101, Glu 137 and Asp 188 in the active site predominantly formed the hydrogen bonds with the top screened compounds. Hence, the drug-like compounds identified can be taken up for the further experimental investigation as anti-tubercular agents.


Assuntos
Antituberculosos/farmacologia , DNA Primase/antagonistas & inibidores , Simulação de Dinâmica Molecular , Domínio Catalítico , DNA Primase/química , Humanos , Mycobacterium tuberculosis
2.
J Biomol Struct Dyn ; 37(16): 4361-4373, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-30466358

RESUMO

The prevailing multi-drug resistance in Mycobacterium tuberculosis continues to remain one of the main challenges to combat tuberculosis. Hence, it becomes imperative to focus on novel drug targets. Filamenting temperature-sensitive mutant Z (FtsZ) is an essential cell division protein, a eukaryotic tubulin homologue and a promising drug target. During cytokinesis, FtsZ polymerises in the presence of GTP to form Z-ring and recruits other proteins at this site that eventually lead to the formation of daughter cells. Benzimidazoles were experimentally shown to inhibit Mtb-FtsZ, with one of the benzimidazole derivatives, M1, being reported to have the minimum inhibitory concentration (MIC) value of 3.13 µg/mL. In the present study, mechanism of destabilisation of FtsZ in the presence of M1 was computationally investigated in the presence of its substrate GTP/GDP employing molecular dynamics (MD) simulation analysis, principal component analysis (PCA), molecular mechanics combined with the generalised Born and surface area continuum salvation (MM-GBSA) and density functional theory (DFT). From the analyses, it is proposed that binding of M1 in the inter-domain cleft induces structural changes in the GTP-binding region that affect GTP binding, thus switching the preference of this protein towards depolymerised state and eventually inhibiting the cell division. Hence, this study provides mechanistic insights into the design of novel benzimidazole inhibitors against Mtb-FtsZ. Communicated by Ramaswamy H. Sarma.


Assuntos
Proteínas de Bactérias/antagonistas & inibidores , Benzimidazóis/química , Proteínas do Citoesqueleto/antagonistas & inibidores , Guanosina Difosfato/química , Guanosina Trifosfato/química , Mycobacterium tuberculosis/efeitos dos fármacos , Regulação Alostérica , Antituberculosos/farmacologia , Proteínas de Bactérias/química , Proteínas de Bactérias/metabolismo , Benzimidazóis/farmacologia , Divisão Celular/efeitos dos fármacos , Proteínas do Citoesqueleto/química , Proteínas do Citoesqueleto/metabolismo , Testes de Sensibilidade Microbiana , Simulação de Dinâmica Molecular , Mycobacterium tuberculosis/metabolismo , Conformação Proteica em alfa-Hélice
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...